Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 8/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.74 |
| ▸ | AR | P10275 | 2/20 | 0.74 |
| ▸ | F2 | P00734 | 1/20 | 0.74 |
| ▸ | NR3C1 | P04150 | 7/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 7/20 | 0.60 |
| ▸ | ABCB11 | O95342 | 3/20 | 0.60 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.60 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.60 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 4/20 | 0.60 |
| ▸ | USP2 | O75604 | 3/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.48 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylprednisolone Aceponate SCHEMBL8961317 | 1.00 | PGR (0.74) | PGRCYP3A4ARF2NR3C1 | |
| Methylprednisolone Aceponate SCHEMBL8612416 | 1.00 | PGR (0.74) | PGRCYP3A4ARF2NR3C1 | |
| SCHEMBL10910516 | 0.95 | PGR (0.67) | PGRCYP3A4ARF2NR3C1 | |
| SCHEMBL10910515 | 0.95 | PGR (0.67) | PGRCYP3A4ARF2NR3C1 | |
| SCHEMBL10881968 | 0.94 | PGR (0.72) | PGRCYP3A4ARF2NR3C1 | |
| SCHEMBL10934308 | 0.94 | PGR (0.72) | PGRCYP3A4ARF2NR3C1 | |
| SCHEMBL10881975 | 0.94 | PGR (0.72) | PGRCYP3A4ARF2NR3C1 | |
| SCHEMBL10902829 | 0.94 | PGR (0.69) | PGRCYP3A4ARF2NR3C1 | |
| SCHEMBL10902825 | 0.94 | PGR (0.69) | PGRCYP3A4ARF2NR3C1 | |
| SCHEMBL10906704 | 0.94 | PGR (0.79) | PGRCYP3A4ARF2NR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3232 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4710918-A1 | OPHTHALMIC PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR, OPHTHALMIC KIT CONTAINING OPHTHALMIC PHARMACEUTICAL COMPOSITION, AND USE | Shenyang Xingqi Pharmaceutical Co., Ltd. (CN) | 2026-03-18 | — | — | EP | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| US-12296043-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2025-05-13 | — | — | US | claimed |
| WO-2025090570-A1 | ANTI-OX40L ANTIBODIES AND METHODS OF USE | ABCELLERA BIOLOGICS INC. (CA) | 2025-05-01 | — | — | WO | claimed |
| EP-4510999-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | Bristol-Myers Squibb Company (US) | 2025-02-26 | — | — | EP | claimed |
| US-20250032513-A1 | Ophthalmic Pharmaceutical Composition, Ophthalmic Kit, and Pharmaceutical Application Thereof | SHENYANG XINGQI PHARMACEUTICAL CO., LTD. (CN) | 2025-01-30 | — | — | US | claimed |
| CN-119212681-A | Method for preparing 3-D printed pharmaceutical products | 百时美施贵宝公司 | 2024-12-27 | — | — | CN | claimed |
| CN-118955596-A | Methylprednisolone aceponate preparation method of nylon | 河南利华制药有限公司 | 2024-11-15 | — | — | CN | claimed |
| US-20240360210-A1 | USE OF AN IL-18 ANTAGONIST FOR TREATING AND/OR PREVENTION OF ATOPIC DERMATITIS OR A RELATED CONDITION | NOVARTIS PHARMA AG (CH) | 2024-10-31 | — | — | US | claimed |
| EP-4426355-A1 | GLYCOSYLATED PRODRUGS | Universiteit Leiden (NL) | 2024-09-11 | — | — | EP | claimed |
| CN-1179721-A | Novel pharmaceutical formulations | ASTRA AB (SE) | 1998-04-22 | — | — | CN | claimed |
| CN-1179718-A | Novel pharmaceutical composition | ASTRA AB (SE) | 1998-04-22 | — | — | CN | claimed |
| EP-0809501-A1 | NOVEL PHARMACEUTICAL FORMULATION | Astra Aktiebolag (SE) | 1997-12-03 | — | — | EP | claimed |
| EP-0809498-A1 | NOVEL PHARMACEUTICAL COMBINATION | Astra Aktiebolag (SE) | 1997-12-03 | — | — | EP | claimed |
| WO-1996024359-A1 | NOVEL PHARMACEUTICAL FORMULATION | ASTRA AKTIEBOLAG (SE) | 1996-08-15 | — | — | WO | claimed |
| WO-1996024355-A1 | NOVEL PHARMACEUTICAL COMBINATION | ASTRA AKTIEBOLAG (SE) | 1996-08-15 | — | — | WO | claimed |
| EP-0675722-A1 | HYDROXY VITAMIN D3 COMPOUNDS FOR TREATING SKIN ATROPHY | LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) | 1995-10-11 | — | — | EP | claimed |
| WO-1994014453-A1 | HYDROXY VITAMIN D3 COMPOUNDS FOR TREATING SKIN ATROPHY | Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) (DK) | 1994-07-07 | — | — | WO | claimed |
| EP-0072547-B1 | 6-ALPHA-METHYL-PREDNISOLONE DERIVATIVES, THEIR PREPARATION AND UTILIZATION | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-03-26 | — | — | EP | claimed |
| EP-0095894-A2 | 6 Alpha-methylprednisolone derivatives | OHTA SEIYAKU KABUSHIKI KAISHA. (JP) | 1983-12-07 | — | — | EP | claimed |